May 14, 2004 |
The Mississippi Supreme Court threw out a $48.5-million damage award against the makers of the heartburn drug Propulsid and ordered that separate trials be held for each of 10 plaintiffs. The justices, in the 6-1 decision, said it was improper to group the 10 plaintiffs together when their claims did not arise out of the same incident. Janssen Pharmaceutica Inc.
September 29, 2001 |
A jury in Port Gibson awarded $100 million to plaintiffs who claimed a drug maker pushed sales of a heartburn product even as the government moved to ban it. Jurors returned the verdict after less than three hours of deliberations in the $1.2-billion suit against drug maker Janssen and its parent company, Johnson & Johnson. Plaintiffs said they suffered anxiety, heart conditions and other health problems after using Propulsid.
December 20, 2000 |
For most of its history, the United States Food and Drug Administration approved new prescription medicines at a grudging pace, paying daily homage to the physician's creed, "First, do no harm." Then in the early 1990s, the demand for AIDS drugs changed the political climate. Congress told the FDA to work closely with pharmaceutical firms in getting new medicines to market more swiftly. President Clinton urged FDA leaders to trust industry as "partners, not adversaries."